Moreover, it has been demonstrated that miR-107 can also modulate cyclin-dependent kinase 5 (CDK5), which is known to be dysregulated in AD, and the metalloproteinase ADAM10, involved in APP processing (Goodall et al., 2013). This evidence concerns the gene CDK5 and Alzheimer disease.